Effects of methysergide on platelets incubated with reserpine

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• Platelets store and transport serotonin (5HT).
• Methysergide is used for migraine prophylaxis and has anti-serotonergic properties.
• Platelets can serve as a model for studying serotonergic mechanisms.

Purpose of the Study:

• To investigate the effects of methysergide and related ergot compounds on platelet serotonin interactions.
• To determine if methysergide affects serotonin uptake or depletion in platelets.
• To explore the potential role of platelet 5HT receptors in methysergide's action.

Main Methods:

• Incubation of human platelets with methysergide, 2-bromo lysergic acid (BOL), ergotamine, methyl ergotamine, and reserpine.
• Assessment of platelet aggregation response to 5HT.
• Measurement of platelet 5HT content and uptake.
• Comparative analysis of the anti-5HT potency of different compounds.

Main Results:

• Methysergide and related compounds (BOL, ergotamine, methyl ergotamine) inhibited the aggregation of platelets induced by 5HT.
• These drugs did not alter the reserpine-induced reduction in platelet 5HT content or 5HT uptake.
• Methysergide demonstrated higher anti-5HT potency than BOL, and methyl ergotamine was more potent than ergotamine.

Conclusions:

• Platelets exhibit 5HT receptor sites that mediate aggregation, which are targeted by methysergide and related ergot derivatives.
• The findings support the use of platelets as a model for synaptic serotonergic preparations.
• The anti-5HT activity of methysergide on platelets may be relevant to its therapeutic effects and side effects in migraine patients.